Shamsoreza Tabriznia Tabrizi, Marzieh Gholampour, Azam Moradi Zarmehri, Mohammad Hadi Sadeghian, Mohammad Reza Keramati
{"title":"2002 - 2013年伊朗呼罗珊-拉扎维地区献血者感染I型人t淋巴细胞病毒的频率和危险因素","authors":"Shamsoreza Tabriznia Tabrizi, Marzieh Gholampour, Azam Moradi Zarmehri, Mohammad Hadi Sadeghian, Mohammad Reza Keramati","doi":"10.4103/nmj.NMJ_127_19","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Human T-cell lymphotropic virus (HTLV-I) is the causative agent for adult T-cell lymphoma/leukemia (ATLL) and HTLV-I-associated myelopathy/tropical spastic paraparesis. The virus is endemic in the parts of Iran. This study is conducted to determine the trends in the frequency of HTLV-I in Mashhad, a city in Khorasan-e Razavi province, Iran, over 11 years.</p><p><strong>Materials and methods: </strong>Blood bank records of blood donors positive for HTLV-I were collected from different blood banks across Mashhad between 2002 and 2013. Obtained data were first entered into paper versions and then were analyzed by SPSS version 11.5. HTLV-I antibody was firstly measured by enzyme-linked immunosorbent assay (ELISA) method and later confirmed by the Western Blot (WB).</p><p><strong>Results: </strong>During the study period, 983,000 donors were examined by ELISA and WB, among whom 2921 cases (0.297%) were positive HTLV-I carriers. The highest and lowest frequency of carriers was 0.451% and 0.098%, respectively. The most significant factor was related to marital status (85.2%) and the smallest significant factor was associated with the history of acupuncture (0.3%) according to the different risk factors.</p><p><strong>Conclusion: </strong>The frequency of HTLV-I carriers among blood donors was significantly decreased in this period. Screening of blood donors for HTLV-I infection played a significant role in this reduction.</p>","PeriodicalId":19223,"journal":{"name":"Nigerian Medical Journal : Journal of the Nigeria Medical Association","volume":"61 3","pages":"151-155"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/54/NMJ-61-151.PMC7547752.pdf","citationCount":"2","resultStr":"{\"title\":\"The Frequency and Risk Factors of Human T-cell Lymphotropic Virus Type I among Blood Donors in Khorasan-e Razavi, Iran, from 2002 to 2013.\",\"authors\":\"Shamsoreza Tabriznia Tabrizi, Marzieh Gholampour, Azam Moradi Zarmehri, Mohammad Hadi Sadeghian, Mohammad Reza Keramati\",\"doi\":\"10.4103/nmj.NMJ_127_19\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Human T-cell lymphotropic virus (HTLV-I) is the causative agent for adult T-cell lymphoma/leukemia (ATLL) and HTLV-I-associated myelopathy/tropical spastic paraparesis. The virus is endemic in the parts of Iran. This study is conducted to determine the trends in the frequency of HTLV-I in Mashhad, a city in Khorasan-e Razavi province, Iran, over 11 years.</p><p><strong>Materials and methods: </strong>Blood bank records of blood donors positive for HTLV-I were collected from different blood banks across Mashhad between 2002 and 2013. Obtained data were first entered into paper versions and then were analyzed by SPSS version 11.5. HTLV-I antibody was firstly measured by enzyme-linked immunosorbent assay (ELISA) method and later confirmed by the Western Blot (WB).</p><p><strong>Results: </strong>During the study period, 983,000 donors were examined by ELISA and WB, among whom 2921 cases (0.297%) were positive HTLV-I carriers. The highest and lowest frequency of carriers was 0.451% and 0.098%, respectively. The most significant factor was related to marital status (85.2%) and the smallest significant factor was associated with the history of acupuncture (0.3%) according to the different risk factors.</p><p><strong>Conclusion: </strong>The frequency of HTLV-I carriers among blood donors was significantly decreased in this period. Screening of blood donors for HTLV-I infection played a significant role in this reduction.</p>\",\"PeriodicalId\":19223,\"journal\":{\"name\":\"Nigerian Medical Journal : Journal of the Nigeria Medical Association\",\"volume\":\"61 3\",\"pages\":\"151-155\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/54/NMJ-61-151.PMC7547752.pdf\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nigerian Medical Journal : Journal of the Nigeria Medical Association\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/nmj.NMJ_127_19\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/7/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nigerian Medical Journal : Journal of the Nigeria Medical Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/nmj.NMJ_127_19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/7/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
摘要
人类t细胞嗜淋巴病毒(HTLV-I)是成人t细胞淋巴瘤/白血病(ATLL)和HTLV-I相关脊髓病/热带痉挛性截瘫的病原体。这种病毒在伊朗部分地区流行。本研究旨在确定11年来伊朗呼罗珊-拉扎维省马什哈德市HTLV-I发病率的趋势。材料与方法:收集2002 - 2013年马什哈德不同血库HTLV-I阳性献血者的血库记录。得到的数据先录入纸质版本,然后用SPSS 11.5版进行分析。先用酶联免疫吸附试验(ELISA)检测HTLV-I抗体,再用Western Blot (WB)证实。结果:研究期间共检测了98.3万名献血者,其中HTLV-I阳性2921例(0.297%)。携带者的最高频率为0.451%,最低频率为0.098%。根据不同的危险因素,最显著的因素是婚姻状况(85.2%),最小的因素是针灸史(0.3%)。结论:献血者中HTLV-I携带者的频率在这一时期明显下降。对献血者进行HTLV-I感染筛查在这一减少中发挥了重要作用。
The Frequency and Risk Factors of Human T-cell Lymphotropic Virus Type I among Blood Donors in Khorasan-e Razavi, Iran, from 2002 to 2013.
Introduction: Human T-cell lymphotropic virus (HTLV-I) is the causative agent for adult T-cell lymphoma/leukemia (ATLL) and HTLV-I-associated myelopathy/tropical spastic paraparesis. The virus is endemic in the parts of Iran. This study is conducted to determine the trends in the frequency of HTLV-I in Mashhad, a city in Khorasan-e Razavi province, Iran, over 11 years.
Materials and methods: Blood bank records of blood donors positive for HTLV-I were collected from different blood banks across Mashhad between 2002 and 2013. Obtained data were first entered into paper versions and then were analyzed by SPSS version 11.5. HTLV-I antibody was firstly measured by enzyme-linked immunosorbent assay (ELISA) method and later confirmed by the Western Blot (WB).
Results: During the study period, 983,000 donors were examined by ELISA and WB, among whom 2921 cases (0.297%) were positive HTLV-I carriers. The highest and lowest frequency of carriers was 0.451% and 0.098%, respectively. The most significant factor was related to marital status (85.2%) and the smallest significant factor was associated with the history of acupuncture (0.3%) according to the different risk factors.
Conclusion: The frequency of HTLV-I carriers among blood donors was significantly decreased in this period. Screening of blood donors for HTLV-I infection played a significant role in this reduction.